Abeona Therapeutics Inc (0H7R.L)

Name: Abeona Therapeutics Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Pharmaceuticals

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$5.4M

Net Income

-$20.5M

Operating Margin

-422.7%

Free Cash Flow

-$84.3M

Debt / Assets

27.5%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Abeona Therapeutics Inc (0H7R.L).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	5,420,000	0	400,000	0
Cost of Revenue	3,700,000	488,000	100,000	0
Gross Profit	1,720,000	-488,000	300,000	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	18,782,000	19,314,000	17,149,000	9,786,000
Operating Expenses	24,631,000	23,530,000	23,092,000	19,727,000
Operating Income	-22,911,000	-24,018,000	-22,792,000	-19,727,000
Interest Expense	884,000	901,000	957,000	998,000
Income Before Tax	-20,675,000	-20,358,000	124,345,000	-12,029,000
Income Tax Expense	-215,000	-15,197,000	15,512,000	0
Net Income	-20,460,000	-5,161,000	108,833,000	-12,029,000
Per Share
EPS	-0.39	-0.10	2.07	-0.24
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Abeona Therapeutics Inc (0H7R.L).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	5,820,000	0	3,500,000	1,414,000
Cost of Revenue	1,532,000	2,907,000	1,605,000	4,577,000
Gross Profit	4,288,000	-2,907,000	1,895,000	-3,163,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	65,031,000	29,851,000	19,004,000	13,129,000
Operating Expenses	93,736,000	61,304,000	49,030,000	42,094,000
Operating Income	-89,448,000	-64,211,000	-47,135,000	-45,257,000
Interest Expense	3,740,000	4,208,000	418,000	736,000
Income Before Tax	71,283,000	-63,734,000	-54,188,000	-39,696,000
Income Tax Expense	100,000	0	0	3,782,000
Net Income	71,183,000	-63,734,000	-54,188,000	-39,696,000
Per Share
EPS	1.34	-1.55	-2.53	-5.05
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Abeona Therapeutics Inc (0H7R.L).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	78,437,000	23,357,000	14,473,000	14,555,000
Short Term Investments	112,967,000	74,363,000	37,753,000	37,932,000
Net Receivables	6,715,000	1,652,000	2,444,000	188,000
Inventory	5,493,000	0	0	0
Total Current Assets	204,906,000	100,853,000	55,737,000	53,099,000
Property Plant Equipment	13,883,000	7,982,000	7,988,000	11,072,000
Goodwill and Intangibles	0	0	0	0
Total Assets	219,570,000	108,931,000	64,002,000	64,214,000
Liabilities
Account Payables	7,889,000	3,441,000	1,858,000	1,811,000
Short Term Debt	13,086,000	6,749,000	998,000	1,773,000
Total Current Liabilities	29,570,000	16,587,000	13,422,000	7,779,000
Long Term Debt	11,882,000	16,299,000	4,402,000	0
Total Liabilities	60,354,000	64,900,000	49,176,000	37,453,000
Shareholders Equity
Retained Earnings	-742,075,000	-813,258,000	-749,524,000	-695,336,000
Total Shareholders Equity	159,216,000	44,031,000	14,826,000	26,761,000

Balance sheet annual history for Abeona Therapeutics Inc (0H7R.L).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	78,437,000	23,357,000	14,473,000	14,555,000
Short Term Investments	112,967,000	74,363,000	37,753,000	37,932,000
Net Receivables	6,715,000	1,652,000	2,444,000	188,000
Inventory	5,493,000	0	0	0
Total Current Assets	204,906,000	100,853,000	55,737,000	53,099,000
Property Plant Equipment	13,883,000	7,982,000	7,988,000	11,072,000
Goodwill and Intangibles	0	0	0	0
Total Assets	219,570,000	108,931,000	64,002,000	64,214,000
Liabilities
Account Payables	7,889,000	3,441,000	1,858,000	1,811,000
Short Term Debt	13,086,000	6,749,000	998,000	1,773,000
Total Current Liabilities	29,570,000	16,587,000	13,422,000	7,779,000
Long Term Debt	11,882,000	16,299,000	4,402,000	0
Total Liabilities	60,354,000	64,900,000	49,176,000	37,453,000
Shareholders Equity
Retained Earnings	-742,075,000	-813,258,000	-749,524,000	-695,336,000
Total Shareholders Equity	159,216,000	44,031,000	14,826,000	26,761,000

Cash flow quarterly history for Abeona Therapeutics Inc (0H7R.L).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	71,183,000	-63,734,000	-54,188,000	-39,696,000
Depreciation & Amortization	3,563,000	2,907,000	3,198,000	4,577,000
Stock Based Compensation	10,779,000	6,628,000	4,768,000	3,051,000
Change in Working Capital	-5,387,000	-4,383,000	-1,788,000	-5,892,000
Operating Cash Flow	-76,326,000	-56,015,000	-37,009,000	-43,483,000
Investing Activities
Capital Expenditure	-7,975,000	-2,446,000	-331,000	-130,000
Investments	-7,975,000	-2,446,000	-331,000	-130,000
Investing Cash Flow	105,028,000	-39,240,000	208,000	-23,964,000
Financing Activities
Debt Repayment	0	20,000,000	0	0
Common Stock Issued/Repurchased	26,077,000	85,628,000	37,389,000	43,173,000
Dividends Paid	0	0	0	0
Financing Cash Flow	26,040,000	104,139,000	37,057,000	43,173,000
Summary
Free Cash Flow	-84,301,000	-58,461,000	-37,340,000	-43,613,000
Net Change in Cash	54,742,000	8,884,000	256,000	-23,374,000

Cash flow annual history for Abeona Therapeutics Inc (0H7R.L).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	71,183,000	-63,734,000	-54,188,000	-39,696,000
Depreciation & Amortization	3,563,000	2,907,000	3,198,000	4,577,000
Stock Based Compensation	10,779,000	6,628,000	4,768,000	3,051,000
Change in Working Capital	-5,387,000	-4,383,000	-1,788,000	-5,892,000
Operating Cash Flow	-76,326,000	-56,015,000	-37,009,000	-43,483,000
Investing Activities
Capital Expenditure	-7,975,000	-2,446,000	-331,000	-130,000
Investments	-7,975,000	-2,446,000	-331,000	-130,000
Investing Cash Flow	105,028,000	-39,240,000	208,000	-23,964,000
Financing Activities
Debt Repayment	0	20,000,000	0	0
Common Stock Issued/Repurchased	26,077,000	85,628,000	37,389,000	43,173,000
Dividends Paid	0	0	0	0
Financing Cash Flow	26,040,000	104,139,000	37,057,000	43,173,000
Summary
Free Cash Flow	-84,301,000	-58,461,000	-37,340,000	-43,613,000
Net Change in Cash	54,742,000	8,884,000	256,000	-23,374,000